Jeffery F. Miller
Fondateur chez Pylum Biosciences, Inc.
Profil
Jeffery F.
Miller is the founder of AvidBiotics Corp.
which was founded in 2005.
He is also the founder of Pylum Biosciences, Inc. Dr. Miller's current job is Chairman-Microbiology & Immunology Department at David Geffen School of Medicine.
Dr. Miller received a doctorate degree from Tufts University School of Medicine.
Postes actifs de Jeffery F. Miller
| Sociétés | Poste | Début |
|---|---|---|
| David Geffen School of Medicine | Corporate Officer/Principal | - |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Fondateur | - |
Anciens postes connus de Jeffery F. Miller
| Sociétés | Poste | Fin |
|---|---|---|
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Fondateur | - |
Formation de Jeffery F. Miller
| Tufts University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AvidBiotics Corp.
AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Health Technology |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Health Technology |